SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Details)	6 Months Ended		12 Months Ended
	Jun. 30, 2024 segment product Institution customer	Jun. 30, 2023 customer	Dec. 31, 2023 customer
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Line Items]
Number of approved commercial products | product	1
Number of operating segments | segment	1
Number of reportable segments | segment	1
Number Of financial institutions | Institution	5
Three Customers | Accounts Receivable | Customer Concentration Risk
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Line Items]
Number of customers | customer	3		3
Concentration risk percentage	100.00%		100.00%
Three Customers | Product Revenues | Customer Concentration Risk
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Line Items]
Number of customers | customer	3	3
Concentration risk percentage	100.00%	100.00%
Accredo Health Group, Inc | Accounts Receivable | Customer Concentration Risk
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Line Items]
Concentration risk percentage	35.00%		39.00%
Accredo Health Group, Inc | Product Revenues | Customer Concentration Risk
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Line Items]
Concentration risk percentage	33.00%	32.00%
Caremark LLC | Accounts Receivable | Customer Concentration Risk
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Line Items]
Concentration risk percentage	41.00%		32.00%
Caremark LLC | Product Revenues | Customer Concentration Risk
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Line Items]
Concentration risk percentage	40.00%	35.00%
PANTHERx Specialty Pharmacy LLC | Accounts Receivable | Customer Concentration Risk
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Line Items]
Concentration risk percentage	24.00%		29.00%
PANTHERx Specialty Pharmacy LLC | Product Revenues | Customer Concentration Risk
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Line Items]
Concentration risk percentage	27.00%	33.00%